MFDS — authorised 30 November 1995
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
🇰🇷 Amaryl in South Korea
MFDS authorised Amaryl on 30 November 1995
Marketing authorisation
Amaryl in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Amaryl approved in South Korea?
Yes. MFDS authorised it on 30 November 1995.
Who is the marketing authorisation holder for Amaryl in South Korea?
SANOFI AVENTIS US holds the South Korean marketing authorisation.